Related Experiment Videos

Expression of kappa opioid receptors in human and monkey lymphocytes

L F Chuang1, T K Chuang, K F Killam

  • 1Department of Medical Pharmacology and Toxicology, University of California, Davis 95616, USA.

Insights

Kappa opioid receptor mRNA is present in human and monkey lymphocytes. Its expression is reduced in monkeys with SIV infection, suggesting a role in immune cell function.

Area of Science:

  • Immunology
  • Neuroscience
  • Molecular Biology

Background:

  • The kappa opioid receptor (KOR) plays a role in various physiological processes.
  • Understanding KOR expression in immune cells is crucial for exploring its immunomodulatory functions.

Purpose of the Study:

  • To investigate the presence and sequence homology of kappa opioid receptor mRNA in human and monkey lymphocytes.
  • To determine if KOR expression in lymphocytes is affected by viral infections like SIV.

Main Methods:

  • Isolation and identification of mRNA encoding the kappa opioid receptor from human lymphocytic cell lines (CEM x174, Jurkat-T4) and primary cells (PBMC, CD4+).
  • cDNA sequence analysis of KOR transcripts, focusing on extracellular loop and transmembrane domains.
  • Detection of KOR mRNA expression in normal and SIV-infected monkey peripheral blood mononuclear cells (PBMC).

Main Results:

  • Kappa opioid receptor mRNA was identified and isolated from various human lymphocyte populations.
  • Human KOR sequences showed high amino acid homology to human placenta and rat brain KOR.
  • KOR mRNA was detected in normal monkey PBMC but significantly reduced in PBMC from SIV-infected monkeys with decreased CD4+ cell counts.

Conclusions:

  • Human and monkey lymphocytes constitutively express kappa opioid receptor mRNA.
  • KOR expression in lymphocytes may be downregulated during viral infections.
  • These findings suggest a potential role for KOR in immune cell function and viral pathogenesis.

Related Concept Videos